Clinical trial No longer in our active list Interventional Ages 18 and up

Using virtual reality to improve walking in ICU patients with weakness

Official title: VERARE_2 Efficacy of the Observation of Virtual Motor Actions for the Improvement of Gait in Patients With ICU Weakness

Run by Rennes University Hospital · NCT04713345 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if using virtual reality can help ICU patients with muscle weakness walk better and recover more effectively.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment66 (estimated)
SponsorRennes University Hospital
Academic / other
Locations1 site (Rennes, Bretagne)
Trial IDNCT04713345 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults hospitalized in ICUs or Continuing Care Units with lower limb muscle weakness due to severe sepsis.

Probably not a fit

Patients with pre-existing gait disorders or central neurological events may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of virtual reality (VR) to enhance rehabilitation for patients suffering from ICU-weakness, a condition characterized by muscle and nerve damage due to prolonged immobilization in intensive care. By observing virtual motor actions, patients may experience improved gait and mobility, which is crucial for their recovery and independence. The intervention aims to provide an alternative rehabilitation method when traditional physiotherapy is not feasible due to patient conditions or resource limitations. The study will include patients hospitalized in ICUs or Continuing Care Units who exhibit lower limb muscle weakness following severe sepsis.

Why it matters

Potential benefit: If successful, this approach could significantly enhance recovery and mobility for ICU patients, leading to faster discharge and improved quality of life.

How similar studies have gone: Other studies have shown promise in using virtual reality for rehabilitation, suggesting potential success for this novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient hospitalized in one of the ICU or Continuing Care Units or at the CHU de Rennes for less than 3 months, and presenting lower limb muscle weakness with MRC motor testing on the main muscle segments giving a score of less than or equal to 48/60 (ICU Weakness diagnostic criterion) in the aftermath of severe sepsis.
* Person of full age;
* Affiliation to a social security scheme;
* Free, informed and signed written consent.

Exclusion Criteria:

* History of a central neurological event with clinical repercussions
* Gait disorders pre-existing to hospitalization in intensive care and limiting the walking perimeter (declaration by the patient) or requiring the use of technical assistance;
* Uncontrolled epilepsy (seizure less than 6 months old);
* Adults who are the subject of legal protection (safeguard of justice, curatorship, guardianship), persons deprived of their liberty;
* Non-French speaking person;
* Pregnant or breastfeeding woman.

Where it's running

  • Rennes University Hospital
    Rennes, Bretagne, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.